EU decides against new directive on GMP for excipients
This article was originally published in SRA
Executive Summary
The European Commission has decided not to go ahead with legislation applying good manufacturing practice provisions to certain excipients after evidence showed it would lead to an increase in costs without providing any public health benefits.